Background: Patient compliance is the cornerstone of compression therapy success. However, there has been up to now no tool to assess it other than self-reporting by the patient, which is not reliable. Material and methods: Forty active females classified C2S were enrolled to wear compression stockings (CS) providing a pressure of 15-20 mmHg at the ankle. A thermal probe was inserted in the stocking (Thermotrack Õ ), recording the skin temperature every 20 min for four weeks. The patients were randomized in two groups of 20:
Background
Compression therapy is the cornerstone of the treatment of Chronic Venous Disorders (CVD), and patient compliance is the key point of therapy success. But, as in other areas of health care, there is a high cost due to patient noncompliance. [1] [2] [3] The most common issue in phlebological practice is that stockings are infrequently prescribed at the primary care level. When prescribed, they are not used by a high proportion of patients. 4 After several years of stocking use and even for severe stages of chronic venous disease, a surprisingly low patient compliance rate of 30-50% has been reported by Raju et al. 5 This suggests that there are problems with the use of CS, and lack of patient education and instructions about compression is likely to be a causative factor. However, intense patient education programs reported in randomized control studies (RCTs) [6] [7] [8] [9] have still shown high levels of patient non-compliance. We note that there is an issue in all these studies: the compliance is only assessed by the patients' self-report and we have no idea of the real compliance.
To our knowledge, this is the very first study reporting the real compliance for the wearing of CS.
Objective
The first aim of this study is to quantify the true patient compliance in using a thermal sensor. (Thermotrack device: http://www.thermotrack.com -''proges'' French company, France.) This device continuously records the skin temperature, making it possible to accurately record the wearing time/days of the CS during the four weeks of the study.
The second aim, by using this sensor, is to assess the effect of the recommendations given by the practitioner as a factor in improving compliance.
Material and methods
Forty-four active females, aged 18 and over, seeking medical care for symptomatic primary chronic venous disorder were enrolled in this study from 1 November 2015 to 15 January 2016. These patients were classified C2S according to the CEAP classification. All patients were asked to carry a cellphone, and were enrolled and followed by the same practitioner for four weeks.
Exclusion criteria were pregnancy, ongoing treatment for CVD, history of deep vein thrombosis, foot static disorders or ankle stiffness or any orthopedic history of the lower limbs.
Patients with a low probability of having symptoms of venous origin were also discarded. For this purpose, we used a specific score (0-4) for symptom imputability 10 ( Table 1 ). The patients with a score less than 3 were excluded.
Study design
This study was organized as a single blind randomized controlled trial. Informed consent was first obtained from all selected patients after an explanation of the study. The patients were then randomized into two groups, each containing 20 subjects: -Group 1: Receiving minimal recommendations about CS use by the physician at the office. -Group 2: Receiving in-depth recommendations by the physician and additional recommendations by SMS messages which were repeated once a week for the four weeks, beginning at day 1.
Details of recommendations given to the group 2 by the practitioner are shown in Figure 1 .
Recommendations sent by SMS message are listed in Table 2 .
No patient declined to participate. Four patients were excluded during the study: one patient from group 2 did not answer the SMS messages, one from group 1 who lost her sensor and two patients whose recorded data of two sensors were not readable at the end of the study. These four excluded patients were replaced to complete the two groups of 20.
All patients received a CS providing a pressure of 15 to 20 mmHg at the ankle -point B (Mediven Õ Elegance French class 2).
Patients could choose either below knee or thigh high stockings, supplied by an experienced fitter who was instructed not to advise on stocking use and did not know the randomization of the patients.
Device used to assess the accurate wearing time for each patient The Thermotrack Õ thermal sensor (Figure 2(a) ) is a small disk recording the temperature every 20 min during the whole duration of the study (four weeks). That makes 4096 measurements that are readable on a personal computer with a USB probe reader (Figure 2(b) ). The patients' data were available through a web server: thermotrackonline.com. (Proges plus company, France). The detailed functions of the server are shown in Table 3 .
The sensors were sewn into each CS (Figure 2(c) ). The accuracy of temperature measurement of this device is 1 C ranging from À40 C to 80 C. The sensor is commonly used to monitor the cold chain of the food industry, and has a certification of qualification for a thermostatic environment (Table 4) .
A thermal curve was obtained for each patient during the four-week trial.
The display of the curves was achieved with excel Õ ''sparklines'' function. The duration of wearing the Figure 1 . Recommendation sheet given to group 2 only and explained by the practitioner at the office. Table 2 . Recommendations given to the group 2 only by SMS message every week, starting at day 1.
SMS message 1:
It is strongly recommended to wear your stockings EVERY DAY. You should practice regularly physical activity such as walking or cycling aiming to stimulate the venous pump of the calf, which drives the blood of your legs upward. SMS message 2: It is strongly recommended to wear your stockings EVERY DAY. Avoid tight clothes which block blood return. SMS message 3: It is strongly recommended to wear your stockings EVERY DAY. Avoid prolonged standing or sitting, trampling and crossing legs. SMS message 4: It is strongly recommended to wear your stockings EVERY DAY. Slightly elevate legs overnight to facilitate venous return Avoid excessive heat that dilates the veins of the legs (saunas, hot baths)
compression stocking was automatically computed using an excel formula from the daily temperature curve by using the number of records above the limit of 26 C ( Figure 3 ). The wearing days were easily computed manually on the curve.
In fact, the average skin temperature of the patients was found to be about 31 C, which was significantly more than the indoor or outdoor temperatures during the trial.
The accuracy and reliability of this thermal sensor to compute the wearing time of the stockings was previously validated by a pilot study 11 presented at the AVF meeting in February 2015.
Parameters assessed during this study
A customized computer program was used, the Computer Venous Registry 12 (CVR), to provide an automated CEAP classification and scoring 10 of the symptoms for each limb. The data entered for each patient included the examination date, birth date, sex, body mass index (BMI), and personal history.
The venous mapping of the superficial and deep systems was performed using color duplex ultrasound in all patients. A basic CEAP classification was documented using the definitions proposed by the expert panel at the 2001 world meeting of the International Union of Phlebology in Roma and revised recently. 13 We did not compute the venous clinical severity score (VCSS), which brings few informations for C2 patients.
In addition, all venous symptoms were also carefully documented using a 10-point visual analogic scale (VAS). Assessed symptoms included pain, heaviness, 
C and þ30 C, the control unit is in accordance with the requirements of type C and type D in relation to usage profiles defined by the NF EN 12830 European standard for the influence of ambient temperature.
RECORDER TEMPERATURE TEST UNDER CONDITIONS OF STORAGE AND TRANSPORT
After testing the recorder at standard-approved storage and transport temperatures, the observed error was between À0.2 C and þ0.5
C. The unit has satisfied the temperature test under conditions of storage and transport, specific to type C and type D climatic environments, as defined by the standard, for internal probe temperature recorders. Consequently, for a measurement range between À30 C and þ30 C, the control unit is in accordance with the requirements of type C and type D in relation to usage profiles defined by the NF EN 12830 European standard for temperature tests under conditions of storage and transport. This test report concerns only the type of equipment submitted to the test. 4. RESPONSE TIME DETERMINATION Response time determined during the course of the test, at 90% of the temperature's real variation, was equal to 5 min. Consequently, the control unit is in accordance with the requirements of the NF EN 12830 European standard for response time of internal probe recorders. 5. RELATIVE TIME RECORDING ERROR The relative time recording error determined during the course of the test represents 0.004% of the recording duration time. The duration of this test was 72 h. Consequently, the control unit is in accordance with the requirements of the NF EN 12830 European standard for maximum relative time error. swollen feeling, pruritus, cramping, burning, restless legs, and venous claudication.
Occurrence of leg symptoms was also assessed using a customized questionnaire that allowed scoring of the symptoms and ascribing them to (the) venous disease, as stated previously (Table 1 ). This score 7 was used as an ''imputability score'' to better identify the venous origin of the symptoms, and to select the patients. The patient-reported QoL was assessed by using the CIVIQ 14 questionnaire, a disease-specific QoL instrument dedicated to chronic venous disorders and validated in this condition. In addition to the global CIVIQ scale, its four dimensions (pain, physical, psychological, and social components) were analyzed separately.
Measurement of the Djian-Annonier angle 15 was performed by the same radiologist in all patients using a standardized measurement protocol.
Venous symptoms VAS and CIVIQ questionnaires were repeated at the conclusion of the four-week study.
Statistical methods
The statistical analysis was performed blinded with JMP software (version 12 pro for Mac). The mean comparison of the wearing durations/days was tested with the Student's t-test with a p < 0.05 considered as significant.
Our hypothesis for the study was that the improvement of the compliance should be about 30%. (from 40% to 70%)
We calculated the number of patients required as 20 in each group (using a bilateral test, with ¼ 0.05, ¼ 0.15, and / ¼ 1). However, this hypothesis was based on no data regarding the real compliance, which has never been evaluated.
Results
The patient characteristics show no difference between the two groups regarding age, BMI, symptoms imputability scoring, pain score, heaviness score, and type of CS (Table 5) .
Comparison of compliance between the two groups
We compared the two groups regarding the daily, weekly and monthly wearing time in hours, the number of days worn (worn days) per week and per month (Table 6) .
We found a very significant difference between the two groups: (Student's t-test).
With recommendations (group 2), the average number of days of wearing the CS for the four weeks of the trial increased by 33%: 18.9 vs. 13.4 in the control group (p < 0.01).
Similarly, the average number of days of wearing the CS each week also increased by 33%: 4.9 in the recommendation group vs. 3.4 in the control group (p < 0.001) (Figure 3) .
However, if we compare the average number of hours on days when the CS were worn by patients in each group, there is no difference (11.1 in the control group vs. 11.6 in group 2). This is the reason why we propose to adopt the average number of days worn per week (proportion of days covered -PDC-see discussion) as the best criterion to assess patient compliance. 
Relationship between wearing time and QoL assessed by CIVIQ
There is a significant correlation between the wearing time and two parameters of the QoL: psychic and social (both p < 0.001). But paradoxally, we found no correlation with the two other parameters of CIVIQ, physical and pain (Figure 4 ).
Discussion
Validation of the Thermotrack Õ device
In our previous pilot study 11 of 10 healthy subjects over one week, we found a perfect correlation of the recorded temperature curve with the daily events reported by the subjects on the questionnaire: 94% of the events (donning, removing, and washing) were identified by the thermo button. This device could be used as a witness to accurately track and control the wearing time of CS on a long-term basis.
Accuracy and reliability of the Thermotrack Õ device are also strongly supported by the industrial reports shown in Table 4 .
However, our study does have several limitations: The first one is the interpretation of the thermal curve: in the present study, the measuring device is around 97% accurate with error range of around 3%.
In fact, the maximum error per recording cycle is 19 min for an average of 11 h of wearing time (which makes about 3%).
The second limitation is regarding the Thermotrack Õ device itself: the external temperature should not exceed 23 C to have a clear cut-off value much lower than the skin temperature (around 30 C). So, this device is not reliable during hot weather.
The third issue is the choice of below-knee or thigh high stockings according to the patients' preference, but this variation was not different in the two groups.
The fourth limitation is that only one single stocking of each pair contained the temperature device so the other stocking may have been worn and the time not recorded, but this is probably similar in the two groups.
The fifth one is the short duration of four weeks for this study. However, it seems that habits developed during the initial period of wearing CS play an important role in long-term compliance (expert advice, as in the French high authority for health report 16 ). A medium-term compliance study of 3-6 months should be done to confirm our results.
Another limitation is that our study was at only one centre.
Lastly, the failure of improvement in the pain score when using the compression, as measured by the CIVIQ is paradoxal in our study, but it could be explained by the small number of patients. In addition, the final pain score was not recorded.
According to the data of the Bonn vein studies, 17 28.7% of the C2 patients are wearing CS, and 38% a compression device including bandages. The Bonn Vein Study 2 also showed that 67.4% of patients who stopped wearing MCS had only temporary reasons for their use (pregnancy, treatments). Therefore, presumably 74% of patients who have a long-term indication regularly wear compression stockings. This is a high level of compliance compared to the other studies.
But the issue in these results is the lack of definition of compliance.
Definition and measurement of the patients' compliance
Compliance can be calculated as both a continuous and dichotomous measure. 18, 19 The proportion of days covered (PDC) is the number of days covered over a time interval (Benner). PDC is obviously the best criteria for assessment of compliance in compression therapy.
If fact, compliance can be assessed by a dichotomous measure (compliant or noncompliant) if a patient attains a specified PDC. This is clearly demonstrated in our study because the improvement in wearing time Figure 4 . Comparison of the wearing time between the two groups: The average day per week is shown in pink; the average hours per wearing day is colored in blue. In the group with recommandations (on the right), we found a significant increase of the patient's compliance for both criteria (p < 0.001).
is achieved by the increase of wearing days and not the average wearing time per day. This is the reason why, for compression therapy, we propose to measure compliance by the wearing days only. For example, a patient wearing a stocking five days out of seven would have a compliance rating of 71% PDC.
Conclusion
To our knowledge, this is the very first study demonstrating actual compliance rates in the wearing of CS. It was accurately measured, thanks to the thermal curve by a small sensor (Thermotrack Õ ) inserted into the stockings.
In this small homogenous group of 40 C2 S women during a four-week period, the extensive and repeated recommendations by SMS given by the practitioner were shown to significantly increase the patients' compliance from 48% in the control group to 71% in the recommendation group, that is 33% (p < 0.001).
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